Mobile Application-based Multifaceted Management to Improve Long-term Care After Percutaneous Coronary Intervention
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1,100
- 主要终点
- evidence-based medication adherence (the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications)
研究概览
简要总结
High rates of recurrent cardiovascular events and readmission after percutaneous coronary intervention (PCI) are important issues. Guidelines emphasize rehabilitation and secondary prevention. But many patients are lack of effective management after PCI.This study is aimed to examine the effect of mobile application (APP)-based multifaceted management on the improvement of long-term care after PCI.
详细描述
This is a cluster-randomized controlled trial to evaluate the effect of APP-based multifaceted management strategy on improvement of long-term care for medication adherence,risk factor control, and reduction of adverse events, readmission rate and mortality after PCI.It includes knowledge education, medication reminder,advice provision, support to change lifestyle behaviors. The program is interactive between care provider and patients. A total of 20 wards will be randomly assigned to intervention or usual care.Anticipated 1100 patients after PCI will be participated in the trial. All the participants will be followed up until 12 months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Single (Outcomes Assessor)
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients who have received percutaneous coronary intervention and are discharged alive in the study centers;
- •patients who are able to use APP;
- •patients who provide informed consent.
排除标准
- •patients who are not able to use APP;
- •dementia;
- •mental disturbed;
- •patients who are not willing to receive management and follow up.
研究组 & 干预措施
control
usual care without APP
intervention
APP-based multifaceted management, including sending education material, everyday medication reminder, giving risk factor control support, clinical support to patients after PCI through APP.
干预措施: APP-based multifaceted management (Other)
结局指标
主要结局
evidence-based medication adherence (the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications)
时间窗: at 12 months after PCI
the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications
次要结局
- rate of systolic blood pressure achieving target(at 12 months after PCI)
- readmission rate(12 months after PCI)
- rate of LDL-C achieving target(at 12 months after PCI)
研究者
Yongjian Wu
Associate director of Coronary Artery Disease Center
Chinese Academy of Medical Sciences, Fuwai Hospital